Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)
China · Delayed Price · Currency is CNY 5.08
+0.01 (0.20%)
Oct 27, 2025, 2:45 PM CST
SHE:002872 Revenue
Tiansheng Pharmaceutical Group had revenue of 116.66M CNY in the quarter ending June 30, 2025, a decrease of -12.57%. This brings the company's revenue in the last twelve months to 520.48M, down -8.27% year-over-year. In the year 2024, Tiansheng Pharmaceutical Group had annual revenue of 569.71M, down -1.66%.
Revenue (ttm)
520.48M
Revenue Growth
-8.27%
P/S Ratio
3.10
Revenue / Employee
409.18K
Employees
1,272
Market Cap
1.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 569.71M | -9.62M | -1.66% |
| Dec 31, 2023 | 579.33M | -27.66M | -4.56% |
| Jan 1, 2023 | 606.99M | -129.69M | -17.61% |
| Jan 1, 2022 | 736.69M | -466.06M | -38.75% |
| Dec 31, 2020 | 1.20B | -476.79M | -28.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |